نتایج جستجو برای: radionuclide therapy
تعداد نتایج: 694054 فیلتر نتایج به سال:
Radioactive waste management is a modern-day issue in terms of radiation safety due to the development radionuclide therapy, emergence new radiopharmaceuticals, radionuclides, and treatment methods, which allow for therapy day hospital. According current domestic regulatory methodological support biological wastes generated during patient’s metabolic activity after injection radiopharmaceutical...
Prostate-specific membrane antigen (PSMA) is a type II transmembrane protein, which is anchored in the cell membrane of prostate epithelial cells. It is highly expressed on prostate epithelial cells and strongly up-regulated in prostate cancer. Although, 177Lu-PSMA has been recently introduced for radionuclide therapy of metastatic castration-resistant prostate cancer (mCRPC) with co...
Effects of radiation on growth of two human tumour cell lines that survived a previous high dose, low dose-rate radionuclide exposure simulating intensive radionuclide therapy, were analyzed. The purpose was to investigate whether the survivors gained therapy induced changes in growth and radiation response. The U118MG, ParRes (parental resistant), and U373MG, ParSen (parental sensitive), gliom...
BACKGROUND Inflammatory immune activation commonly occurs in heart failure and may perpetuate this syndrome. We sought to determine whether the immunomodulating agent pentoxifylline enhances left ventricular function in patients with ischemic cardiomyopathy. We also investigated the effect of therapy on levels of brain natriuretic peptide (NT-pro BNP), C-reactive protein (CRP), tumor necrosis f...
PURPOSE Radionuclide reporter gene imaging holds promise for non-invasive monitoring of transplanted stem cells. Thus, the feasibility of utilizing recombinant baculoviruses carrying the sodium iodide symporter (NIS) reporter gene in monitoring stem cell therapy by radionuclide imaging was explored in this study. METHODS Recombinant baculoviruses carrying NIS and green fluorescent protein (GF...
The article reviews the background and current status of pretargeting for cancer imaging and therapy with radionuclides. Pretargeting procedures were introduced approximately 20 years ago as an alternative to directly radiolabeled antibodies. Because they were multistep processes, they were met with resistance but have since progressed to simple and improved procedures that could become the nex...
The proceedings of a MIRD-sponsored continuing medical education session entitled, “Kidney Dose–Response for Radionuclide Therapy,” held at the 50th Annual Meeting of the Society of Nuclear Medicine, in New Orleans in 2003, have been collected in this special section of Cancer Biotherapy & Radiopharmaceuticals. A few years ago, hematologic toxicity was the focus of concern in radionuclide thera...
نمودار تعداد نتایج جستجو در هر سال
با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید